Market Overview

Rite Aid Falls On Technical Focus

Related RAD
Rite Aid And Physician Direct ACO Partner To Expand Rite Aid Health Alliance Program
Weekly Highlights: Apple Vs. Retailers, Hewlett-Packard Innovation And More
Good Time to Buy RAD? (Fox Business)

Shares of Rite Aid (NYSE: RAD) are down 4.4 percent amid investor speculation on common trends in its price graph.

Rite Aid has been testing the $7 price level since the drug retailer's positive Q4 earnings release in April, followed by a short-lived rally to all-time highs of $8.61. Following Rite Aid's rally from late April to early June, shares faced a modest sell-off, retracing back to the low $7 range.

It appears that traders have identified the $7 price level as a focus, being right above the mean 50 percent level year to date.

Posted-In: Movers Tech

 

Related Articles (RAD)

Around the Web, We're Loving...

Get Benzinga's Newsletters